Abstract: The invention relates to the use of compounds of the formula I in which X is the divalent radical of oxygen, a carbonyl radical, optionally aliphatically substituted imino or the radical ═CR9R10, Y is a carbonyl group or the radical ═CR9R10, R1 and R2 are identical or different electron-withdrawing radicals, chosen from the group consisting of cyano, alkyl- or arylcarbonyl, alkyloxy- or aryloxycarbonyl, optionally substituted aminocarbonyl, alkyl- or arylsulfinyl, alkyl- or arylsulfonyl and optionally substituted aminosulfonyl, R3 is a hydrogen atom, a cyano, hydroxyl, carboxyl or aminocarbonyl group or a C5-C20-aryl radical or C1-C20-alkylradical optionally bonded via an oxygen bridge, an aminocarbonyl bridge or oxycarbonyl bridge, R4 is a hydrogen atom, a hydroxyl group, an amino group, or a C5-C20-aryl radical or C1-C20-alkyl radical optionally bonded via an oxygen bridge, and R5 to R10 independently of one another are hydrogen or C1-C20-alkyl radicals and where in additio

Abstract: A composition that includes Sea Buckthorn Oil may be used as a cosmetic product, a pharmaceutical or nutraceutical product or a food product. The composition maintains its distinctive color, due to the use of Sea Buckthorn Oil, over time, even when exposed to oxygen and/or U.V. light. The color of Sea Buckthorn Oil is maintained by adding to the composition Sea Buckthorn Oil in an amount from 0.01 to 90% by weight and an antioxidant and/or a U.V. filter in an amount from 0.001 to 20% by weight.

Abstract: A gelled oil composition containing an emulsifier, a gelling agent, an oil, and a surfactant which, when applied to the skin in the presence of water, produces a significant amount of foam. After the composition is rinsed from the skin, a non-greasy, oil residue is left thereon.

Abstract: This invention provides compositions and methods useful for repelling target pests. The compositions comprise an amount of a monoterpenoid or sesquiterpenoid effective to repel a target pest from a target area, the monoterpenoid or sesquiterpenoid in combination with a carrier. In one embodiment, the monoterpenoid or sesquiterpenoid is from a biorational source, such as a plant volatile. In a particular embodiment, the plant volatile is a monoterpenoid, such as “nepetalactone” (or the individual nepetalactone isomers) derived from catnip (Nepeta cataria). In another embodiment, the plant volatile is any one or a combination of sesquiterpenoids derived from the fruit of the Osage orange tree (Maclura pomifera). Such compositions have repellency against arthropods, such as cockroaches, mosquitoes, mites, ticks, spiders, and so forth.

Abstract: Disclosed are antiperspirant and deodorant compositions and corresponding methods of application, wherein the compositions are single-phase systems that comprise a solubilized antiperspirant active, a silicone elastomer and a volatile silicone. These compositions provide improved low residue performance, enhanced stability, and improved cosmetics.

Abstract: A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.

Abstract: A composition for improving memory and concentration in mammals with disorders associated with memory impairment. The composition comprises a combination of at least one phytoestrogen and at least one acetylcholinesterase inhibitor such as Huperzine A, or any derivative, analog, metabolite or combination thereof. The composition may further include at least one mammalian estrogen. The method of the invention comprises the co-administration of at least one phytoestrogen and at least one acetylcholinesterase inhibitor in a therapeutically effective amount. Additionally, a mammalian estrogen may be co-administered.

Abstract: The invention is of a topical medicament and associated methodology for use thereof, through the use of which Peyronie's disease may be effectively, cost effectively, and painlessly treated. The primary active ingredient is a calmodulin blocker, the preferred such ingredient being trifluroperizine.

Abstract: This invention relates to disinfectant concentrates having improved biocidal activity containing an aldehyde, such as glutaraldehyde, a glycol and a lithium based buffer.

Abstract: A method of arresting the flow of blood and other protein containing body fluids flowing from an open wound and for promoting wound healing. In the method, a substantially anhydrous compound of a salt ferrate is provided for a unique use which, when hydrated after mixing with a victim's own blood or other aqueous media, produces Fe+++ thereby promoting clotting when applied in a paste form to the wound for a time sufficient to arrest substantial further blood and other body fluid flow from the wound. The compound is formed of a ferrate (VI) salt taken from the group consisting of H, Li, Na, K, Rb, Cs and Fr. However, to decrease or eliminate stinging sensation, the compound may be formed having a ferrate (VI) salt taken from the group consisting of Be, Mg, Ca, Sr, Ba, Ra, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, In, Sn, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, TI, Pb, Bi, Al, As, NH4 and N(C4H9)4.

Abstract: Damaged or imperfect hair shafts are treated by: (a) hydrating hair shafts to open flaps of the cuticles layer, (b) applying to the hair shafts amino acids or peptides effective to nourish hair, and (c) compressing the hair shafts under heat by sandwiching the hair shafts between heated plates to cause the amino acids or peptides to penetrate through the cuticle layer and close the openings between the flaps. The penetrated amino acids or peptides nourish the cortex. The hair shafts may be subjected to hair styling treatment.

Abstract: Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.

Abstract: A powder for use in a dry powder inhaler includes active particles and carrier particles for carrying the active particles. The powder further includes additive material (4) on the surfaces of the carrier particles to promote the release of the active particles from the carrier particles on actuation of the inhaler. The powder is such that the active particles are not liable to be released from the carrier particles before actuation of the inhaler. The inclusion of additive material (4) in the powder has been found to give an increased respirable fraction of the active material.

Abstract: There are disclosed cosmetic compositions and methods for protection of keratinous tissue against environmental aggressors, such as smoke, smog and UV radiation. The compositions have as an essential antioxidant: (i) hesperetin, (ii) tetrahydrocurcumin, (iii) tetrahydrodemethoxycurcumin, or (iv) tetrahydrobisdemethoxycurcumin, or mixtures of thereof. The compositions are preferably in the form of oil in water emulsions and may optionally contain one or more emulsifiers, preservatives, thickeners, sunscreens, additional antioxidants, emollients, skin protectants, hair protectants, nail protectants and the like.

Abstract: The invention concerns the use of at least one auxin in a cosmetic composition as agent for stimulating the synthesis of skin lipids.

Abstract: A method of delivering benzindene prostaglandins to a patient by inhalation is discussed. A benzindene prostaglandin known as UT-15 has unexpectedly superior results when administered by inhalation compared to parenterally administered UT-15 in sheep with induced pulmonary hypertension.

Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.

Abstract: The present invention relates to a method for sequestering bile acids in a patient and to particular polymers for use in the method. The invention further relates to a method for reducing blood cholesterol, treating atherosclerosis, treating hypercholesterolemia and/or reducing plasma lipid content of a mammal. The methods of the invention comprise orally administering to the patient a therapeutically effective amount of a polymer characterized by a polyether backbone and amino or ammonium groups pendant therefrom. The amino nitrogen atoms can be substituted by one or more substituents independently selected from among substituted and unsubstituted, normal, branched and cyclic alkyl groups, and aryl groups. When the polymer comprises pendant ammonium or quaternary ammonium groups, the polymer will be associated with a pharmaceutically acceptable anion.

Abstract: Disclosed herein is a tableted oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extragranular polymer matrix which is more rapidly hydrating than the intragranular polymer. The amino acid is selected for hydropathy characteristics depending on solubility characteristics of the active compound.

Abstract: An antiperspirant suspension which is finely divided, which is contained in a non-aqueous phase, and which has improved efficacy for perspiration reduction when used on human skin, includes at least one basic aluminum-zirconium-halogenohydrate complex as active ingredient in which at least 60% of the zirconium content can be directly titrated after dissolving in 0.1 n HCl with EDTA at a pH of 0.8, wherein the active ingredient optionally contains an amino acid. A process for the synthesis of the antiperspirant suspension includes mixing an aluminum salt which is effective as an antiperspirant with a zirconium salt which is effective as an antiperspirant, optionally in the presence of an amino acid, in a non-aqueous oil phase in the absence of water to provide a mixture; and grinding the mixture.